INGESTION OF ACAPSULAR CRYPTOCOCCUS-NEOFORMANS OCCURS VIA MANNOSE ANDBETA-GLUCAN RECEPTORS, RESULTING IN CYTOKINE PRODUCTION AND INCREASEDPHAGOCYTOSIS OF THE ENCAPSULATED FORM
Ce. Cross et Gj. Bancroft, INGESTION OF ACAPSULAR CRYPTOCOCCUS-NEOFORMANS OCCURS VIA MANNOSE ANDBETA-GLUCAN RECEPTORS, RESULTING IN CYTOKINE PRODUCTION AND INCREASEDPHAGOCYTOSIS OF THE ENCAPSULATED FORM, Infection and immunity, 63(7), 1995, pp. 2604-2611
Cryptococcus neoformans is a pathogenic yeast and a major cause of opp
ortunistic infection in AIDS patients, It is commonly found in an acap
sular form in the environment, and infection is likely to occur by inh
alation. The lung provides a suitable environment for capsule synthesi
s, and once encapsulated, C. neoformans becomes resistant to phagocyto
sis, A stable acapsular mutant of the organism is readily ingested by
murine macrophages in vitro, indicating entry via constitutively compe
tent receptors, We demonstrate In this report that this process is inh
ibitable by particles derived from Saccharomyces cerevisiae that are r
ich in mannan and beta-glucan, as well as more purified forms of these
glycans, Furthermore, ingestion of the acapsular form of C. neoforman
s induces a range of proinflammatory cytokines, including tumor necros
is factor alpha and granulocyte-macrophage colony-stimulating factor,
which, as we have previously shown, enhance ingestion of serum opsoniz
ed encapsulated C. neoformans in vitro, We demonstrate that ingestion
of the acapsular form of the organism also enhances ingestion of the p
athogenic encapsulated form, This is dependent on the production of tu
mor necrosis factor alpha and granulocyte-macrophage colony-stimulatin
g factor by the macrophages, since addition of neutralizing antibodies
to both cytokines inhibited the observed increase in ingestion, Toget
her, these data demonstrate that ingestion of acapsular C. neoformans
is mediated via mannose and beta-glucan receptors on the macrophage su
rface and that this process activates macrophages for enhanced phagocy
tosis of the encapsulated form via production of macrophage-derived cy
tokines.